BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams.
Company Location
4505 Emperor Blvd., Suite 200
Durham
NC
27703
Phone
County
Region
Company Details
Company type
Year founded
1986
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products on market
RAPIVAB® (antiviral treatment for influenza); ORLADEYO® (for hereditary angioedema)
Products under development
BCX10013 (Factor D inhibitor); Avoralstat (Plasma kallikrein inhibitor); BCX17725 (KLK5 inhibitor)